Results 51 to 60 of about 60,915 (280)
Objective: to evaluate the completeness of screening for hepatitis B virus (HBV) infection in HBsAg-positive patients admitted to a rheumatology hospital and to follow the history of HBV reactivation/seroversion during antirheumatic therapy.
G. I. Gridneva +2 more
doaj +1 more source
Serum Midkine as a Biomarker for Hepatocellular Carcinoma Treatment Response and Prognostication
Up‐to‐date, tumor markers are considered more helpful in the evaluation of treatment response and prognostication rather than diagnosis. Identifying a valid biomarker to help clinical management of hepatocellular carcinoma (HCC) is still a challenge, especially the alpha‐fetoprotein (AFP) negative HCC. This study evaluated the efficacy of serum Midkine
Yanfang Luo +3 more
wiley +1 more source
Infectious agents and chemical substances can trigger the production and the release of cytokines. To determine the pattern of infectious agents in herbal homes patients with elevated TNFα (≥ 5.0 pg/ml) in Saki – West-Nigeria.
Mathew Folaranmi Olaniyan +1 more
doaj +1 more source
Batman’da gebelerde ve HBsAg pozitif anneden doğan yenidoğanlarda HBsAg seroprevalansı
İstanbul Bilim Üniversitesi, Tıp Fakültesi.Objectives: The aim of this study was to determine hepatitis B surface antijen (HBsAg) seroprevalence among pregnant women and neonates born to HBsAgpositive mothers admitted to Batman Gynecology, Obstetrics and
Şentürk, Mehmet Baki +6 more
core +1 more source
In nonspecialist departments, most anti‐HCV–positive individuals do not proceed to RNA testing. The Elecsys HCV Duo assay simultaneously detects anti‐HCV antibodies and core antigen from a single blood draw and preferentially identifies patients with clinically meaningful viral loads.
Hiroko Setoyama +23 more
wiley +1 more source
Soluble B7‐H6 as a Novel Diagnostic Biomarker for Post‐Hepatitis B Cirrhosis: A Clinical Value Study
This study investigates the potential of soluble B7‐H6 (sB7‐H6) as a novel diagnostic biomarker for post‐hepatitis B cirrhosis. The infographic visually presents the following key points: (1) Liver Disease Progression: Chronic hepatitis B (CHB) progresses to liver cirrhosis (LC), with serum sB7‐H6 levels increasing stepwise as the disease advances. (2)
Kaiyong Chen +4 more
wiley +1 more source
Alemayehu Sayih Belay,1 Dejene Derseh Abateneh,1,2 Sisay Shewasinad Yehualashet,1,3 Kindie Mitiku Kebede1 1Mizan Tepi University, College of Health Sciences, Mizan Aman, Ethiopia; 2Kotebe Metropolitan University, Menelik II College of Medicine and Health
Belay AS +3 more
doaj
Prevalence of Hepatitis B Virus among Pregnant Women Attending Antenatal Care in Alexandria
Background & Hepatitis B infection is a very serious public health problem. Perinatal vertical transmission is a common mode of transmission. Infants infected from their mothers will have a very high risk of developing chronic liver disease. Objective(s):
Marwa M. Fekry +4 more
doaj +1 more source
Recent advances in the treatment of chronic hepatitis B: where to start initial therapy?
This review summarizes recent advances in the study of the efficacy and safety of antiviral therapy in patients with chronic hepatitis B. Describe the modern concept of monitoring and treatment of these patients.
K. V. Zhdanov
doaj +1 more source
When Fat Goes Astray: Your Liver and Pancreas Get Into Trouble
Metabolic dysfunction‐associated steatotic liver disease (MASLD) and intrapancreatic fat deposition (IPFD) are both common manifestations of ectopic fat accumulation. Although they share multiple risk factors, they also show notable differences in pathological features, standardization of diagnosis, and research maturity.
Yuying Chen +5 more
wiley +1 more source

